CRISPR Cuts
Leading St. Jude’s Genome Engineering Capabilities: A Chat with Shondra Miller

Leading St. Jude’s Genome Engineering Capabilities: A Chat with Shondra Miller

January 28, 2020

Shondra Miller shares her experience of starting a shared genome engineering resource at the St. Jude Children's Research Hospital. Learn more about her research projects and her views on the past, present, and future of the genome editing field in this podcast episode.

The Potential of CRISPR Editing in Stem Cells: An Interview with Bill Skarnes

The Potential of CRISPR Editing in Stem Cells: An Interview with Bill Skarnes

November 13, 2019

Dr. Bill Skarnes, Professor at The Jackson Laboratory, chats about how CRISPR edited stem cells are becoming a gold standard to study gene function and disease modeling. 

CRISPR in Fungi: An Interview with Rebecca Shapiro

CRISPR in Fungi: An Interview with Rebecca Shapiro

September 4, 2019

Rebecca Shapiro, Assistant Professor at the University of Guelph, talks about CRISPR genome editing in fungal pathogens to understand their disease-causing mechanism. Her lab also works on gene drives in fungi for studying large scale genetic interactions and developing ways for treating fungal biofilms.

Paul Dabrowski Gets Candid About the Past, Present, and Future of Synthego

Paul Dabrowski Gets Candid About the Past, Present, and Future of Synthego

August 7, 2019

In this interview, Paul Dabrowski, CEO of Synthego, talks about how Synthego got started, his mantra behind leading the company, and future directions. He also offers insights into Synthego’s unique capabilities⁠—the powerful combination of engineering and biology that enable scaling.

Dana Foss is Solving the CRISPR Delivery Problem to Advance Therapeutics

Dana Foss is Solving the CRISPR Delivery Problem to Advance Therapeutics

May 22, 2019

CRISPR has great potential in therapeutics, but CRISPR delivery in vivo remains a challenge. Researcher Dana Foss discusses her lab’s novel approach for specific delivery of CRISPR components in cells and tissues.

SHERLOCK Founders Crack the Case of CRISPR Diagnostics

SHERLOCK Founders Crack the Case of CRISPR Diagnostics

May 8, 2019

CRISPR is going beyond gene editing into a new area: diagnostics. Omar Abudayyeh and Jonathan Gootenberg, co-founders of SHERLOCK Biosciences, talk about the present advances and future of CRISPR diagnostics. 

Kiana Aran Chats About Her New Biosensor: CRISPR-Chip

Kiana Aran Chats About Her New Biosensor: CRISPR-Chip

April 18, 2019

Kiana Aran, a biomedical engineering expert, talks about her research on CRISPR-Chip, a new biosensor that combines CRISPR & electronics to detect specific genes in genomic DNA.

How the Innovative Genomics Institute is Helping People Understand CRISPR

How the Innovative Genomics Institute is Helping People Understand CRISPR

March 19, 2019

Megan Hochstrasser, Science Communications Manager at the Innovative Genomics Institute, talks about the importance of CRISPR science communication and the ongoing efforts at IGI to help people understand this genome engineering tool.

Improving Targeted Delivery to Enhance Personalized Medicine

Improving Targeted Delivery to Enhance Personalized Medicine

February 26, 2019

Andre Watson, CEO of Ligandal, talks about how his company is improving the payload delivery of gene therapy, making it more accurate and efficient, to make new gene therapy a reality for the public.

Alex Philippidis Reviews Trends in Biopharma & Biotech Market

Alex Philippidis Reviews Trends in Biopharma & Biotech Market

February 7, 2019

Biotech and biopharma companies are in a phase of accelerated growth. Alex Philippidis, a science journalist at Genetic Engineering & Biotechnology News discusses the changing face of big pharma, biotech, and CRISPR gene editing industries, as they raise more money and the world changes around them.